- Report
- April 2023
- 110 Pages
Global
From €4322EUR$4,750USD£3,691GBP
- Report
- April 2023
- 115 Pages
Global
From €4322EUR$4,750USD£3,691GBP
- Report
- July 2024
- 100 Pages
Global
From €3412EUR$3,750USD£2,914GBP
- Report
- July 2024
- 100 Pages
Global
From €3412EUR$3,750USD£2,914GBP
- Report
- September 2022
- 120 Pages
Global
From €4094EUR$4,500USD£3,497GBP
- Report
- March 2026
- 200 Pages
Saudi Arabia
From €2537EUR$2,789USD£2,167GBP
- Report
- March 2026
- 200 Pages
Mexico
From €2537EUR$2,789USD£2,167GBP
- Report
- June 2025
- 400 Pages
Global
From €4503EUR$4,949USD£3,846GBP
- Report
- June 2025
- 300 Pages
North America
From €3520EUR$3,869USD£3,006GBP
- Report
- June 2025
- 250 Pages
United States
From €2537EUR$2,789USD£2,167GBP
- Report
- June 2025
- 250 Pages
United Kingdom
From €2537EUR$2,789USD£2,167GBP
- Report
- June 2025
- 300 Pages
Europe
From €3520EUR$3,869USD£3,006GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2537EUR$2,789USD£2,167GBP
- Report
- June 2025
- 400 Pages
Global
From €4503EUR$4,949USD£3,846GBP
- Report
- April 2023
- 147 Pages
Global
From €4503EUR$4,949USD£3,846GBP
- Report
- February 2025
- 149 Pages
Global
From €3594EUR$3,950USD£3,069GBP
- Report
- June 2024
- 231 Pages
Global
From €4544EUR$4,995USD£3,881GBP
- Report
- March 2024
- 308 Pages
Global
€4544EUR$4,995USD£3,881GBP
- Report
- July 2026
- 160 Pages
Saudi Arabia
From €3776EUR$4,150USD£3,225GBP
- Report
- July 2024
- 156 Pages
Global
From €3093EUR$3,400USD£2,642GBP
€3867EUR$4,250USD£3,302GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more